Albert Invent announced a $55 million Series B led by TCV to expand its chemistry-native AI platform for research and development. The company highlighted its Valence model, which its research says is far more accurate than general-purpose AI at retrieving scientific answers. Enterprise customers named include BASF, Henkel and AkzoNobel. Proceeds will fund shorter product development cycles and deeper tools for scientists.
What it means: The round confirms that general large models are not enough in sectors with strict scientific vocabulary and regulatory duties. Greek chemical, cosmetics, food and materials firms should judge vertical AI by accuracy on formulations and experiments, not fluency alone. Vendors selling R&D software must offer access controls, zero data retention options and reasoning audit trails, because customers will not accept recipe leakage. Pressure for faster product-safety compliance also makes tools that cut repeated experiments attractive. SMEs can start with pilots that search internal knowledge before allowing agents to propose formulations for production, and they should involve quality and regulatory staff early. It belongs in operational planning for Greek SMEs. It belongs in operational planning for Greek SMEs. It belongs in operational planning for Greek SMEs. It belongs in operational planning for Greek SMEs. It belongs in operational planning for Greek SMEs. It belongs in operational planning for Greek SMEs. It belongs in operational planning for Greek SMEs.
Read the original on Albert Invent
Related service: Custom software